A L Jackman - JoVE Visualize

Showing results (1-10 of 86) with videos related to

Pageof 9

Sort By:

Anti-Cancer Drugs|January 1, 1997

Folate-based thymidylate synthase inhibitors in cancer chemotherapyY Takemura, A L Jackman

Current Medicinal Chemistry|July 21, 1998

Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agentsV Bavetsias, A L Jackman

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995

Folate-based thymidylate synthase inhibitors as anticancer drugsA L Jackman, A H Calvert

Journal of Chromatography. B, Biomedical Sciences and Applications|September 19, 2000

Modified high-performance liquid chromatography assay for the measurement of 2'-deoxyuridine in human plasma and its application to pharmacodynamic studies of antimetabolite drugsF Mitchell, S Lynn, A L Jackman

Biochemical Pharmacology|May 8, 1992

Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthaseW H Ward, R Kimbell, A L Jackman

European Journal of Cancer (Oxford, England : 1990)|January 25, 2000

Combination of raltitrexed with other cytotoxic agents: rationale and preclinical observationsA L Jackman, R Kimbell, H E Ford

Biochemical Pharmacology|December 15, 1983

Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cellsR C Jackson, A L Jackman, A H Calvert

Advances in Experimental Medicine and Biology|January 1, 1993

The history of the development and clinical use of CB 3717 and ICI D1694S J Clarke, A L Jackman, I R Judson

Investigational New Drugs|January 1, 1996

Tomudex (ZD1694): from concept to care, a programme in rational drug discoveryA L Jackman, F T Boyle, K R Harrap

Biochemical Pharmacology|May 17, 1996

Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cellsG W Aherne, A Hardcastle, F Raynaud, et al.

Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:

Pageof 9

Anti-Cancer Drugs|January 1, 1997

Folate-based thymidylate synthase inhibitors in cancer chemotherapyY Takemura, A L Jackman

Current Medicinal Chemistry|July 21, 1998

Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agentsV Bavetsias, A L Jackman

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995

Folate-based thymidylate synthase inhibitors as anticancer drugsA L Jackman, A H Calvert

Journal of Chromatography. B, Biomedical Sciences and Applications|September 19, 2000

Modified high-performance liquid chromatography assay for the measurement of 2'-deoxyuridine in human plasma and its application to pharmacodynamic studies of antimetabolite drugsF Mitchell, S Lynn, A L Jackman

Biochemical Pharmacology|May 8, 1992

Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthaseW H Ward, R Kimbell, A L Jackman

European Journal of Cancer (Oxford, England : 1990)|January 25, 2000

Combination of raltitrexed with other cytotoxic agents: rationale and preclinical observationsA L Jackman, R Kimbell, H E Ford

Biochemical Pharmacology|December 15, 1983

Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cellsR C Jackson, A L Jackman, A H Calvert

Advances in Experimental Medicine and Biology|January 1, 1993

The history of the development and clinical use of CB 3717 and ICI D1694S J Clarke, A L Jackman, I R Judson

Investigational New Drugs|January 1, 1996

Tomudex (ZD1694): from concept to care, a programme in rational drug discoveryA L Jackman, F T Boyle, K R Harrap

Biochemical Pharmacology|May 17, 1996

Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cellsG W Aherne, A Hardcastle, F Raynaud, et al.

Pageof 9